SCHEMBL4016181

SCHEMBL4016181

CC(C)Cn1c(-c2c[nH]nc2Cc2cccc(F)c2)nc2[nH]c(=O)[nH]c(=O)c21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
ADORA2B P29275 4/20 0.40
ADORA3 P0DMS8 3/20 0.40
ADORA2A P29274 3/20 0.38
ADORA1 P30542 3/20 0.38
THRB P10828 2/20 0.38
ALDH1A1 P00352 2/20 0.38
DPP4 P27487 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35
ATM Q13315 1/20 0.35
CASR P41180 1/20 0.34
KDM1A O60341 1/20 0.34
IDH1 O75874 1/20 0.34
NOD1 Q9Y239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4014400 0.85 ADORA2A (0.41) MEN1KMT2AADORA2BADORA3ADORA2A
SCHEMBL4019166 0.85 NOD1 (0.37) MEN1KMT2AADORA2BADORA3ADORA1
SCHEMBL4293285 0.78 BRD4 (0.39) DPP4
SCHEMBL4283981 0.78 TPH1 (0.34) ADORA2BADORA2AADORA1DPP4CASR
SCHEMBL4016921 0.77 ADORA2B (0.41) ADORA2BADORA3ADORA2AADORA1LMNA
SCHEMBL4284310 0.77 KDM1A (0.54) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL4019325 0.76 LMNA (0.42) ALDH1A1LMNAHPGDHTT
SCHEMBL4295147 0.75 MAOB (0.40) LMNAHTT
SCHEMBL4291739 0.74 KDM1A (0.60) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL4285483 0.73 MEN1 (0.54) MEN1KMT2AALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009088518-A1 A2B ADENOSINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CANCER CV THERAPEUTICS, INC. (US) 2009-07-16 WO disclosed